Gilead Sciences Inc. (GILD) has announced the pricing of senior unsecured notes, totaling an aggregate principal amount of $3.5 billion, through an underwritten, registered public offering. This offering includes $750 million of 4.80% senior notes due in 2029, $1 billion of 5.10% senior notes due in 2035, $1 billion of 5.50% senior notes due in 2054, and $750 million of 5.60% senior notes maturing in 2064.
The closing of this offering is anticipated to take place on November 20, 2024.
Gilead has specified that the net proceeds from this issuance are intended for general corporate purposes, which could include the repayment of existing debt.
